Brown Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,260,466
| Closed | -$310M | – | 129 |
|
|
2022
Q3 | $310M | Sell |
1,260,466
-1,993
| -0.2% | -$538K | 4.34% | 8 |
|
|
2022
Q2 | $312M | Sell |
1,262,459
-116,346
| -8% | -$31.4M | 4.18% | 7 |
|
|
2022
Q1 | $457M | Sell |
1,378,805
-34,013
| -2% | -$10.5M | 4.55% | 7 |
|
|
2021
Q4 | $507M | Sell |
1,412,818
-17,686
| -1% | -$5.98M | 4.2% | 10 |
|
|
2021
Q3 | $466M | Sell |
1,430,504
-110,968
| -7% | -$37.6M | 3.81% | 10 |
|
|
2021
Q2 | $481M | Sell |
1,541,472
-60,077
| -4% | -$18.4M | 3.65% | 13 |
|
|
2021
Q1 | $510M | Sell |
1,601,549
-17,299
| -1% | -$5.54M | 3.8% | 9 |
|
|
2020
Q4 | $525M | Buy |
1,618,848
+767
| +0% | +$212K | 3.63% | 10 |
|
|
2020
Q3 | $448M | Sell |
1,618,081
-12,291
| -0.8% | -$3.54M | 3.72% | 11 |
|
|
2020
Q2 | $394M | Sell |
1,630,372
-11,085
| -0.7% | -$2.23M | 3.39% | 13 |
|
|
2020
Q1 | $238M | Buy |
1,641,457
+11,865
| +0.7% | +$1.97M | 2.76% | 16 |
|
|
2019
Q4 | $278M | Buy |
1,629,592
+3,050
| +0.2% | +$565K | 2.66% | 18 |
|
|
2019
Q3 | $289M | Buy |
1,626,542
+268,066
| +20% | +$57.9M | 2.81% | 18 |
|
|
2019
Q2 | $354M | Buy |
1,358,476
+125,857
| +10% | +$33.4M | 3.36% | 15 |
|
|
2019
Q1 | $352M | Sell |
1,232,619
-8,526
| -0.7% | -$2.83M | 3.56% | 12 |
|
|
2018
Q4 | $403M | Sell |
1,241,145
-22,066
| -2% | -$7.67M | 4.85% | 4 |
|
|
2018
Q3 | $568M | Buy |
1,263,211
+3,435
| +0.3% | +$1.35M | 5.16% | 4 |
|
|
2018
Q2 | $515M | Sell |
1,259,776
-149,644
| -11% | -$54.2M | 5.29% | 1 |
|
|
2018
Q1 | $410M | Sell |
1,409,420
-20,727
| -1% | -$5.25M | 4.66% | 7 |
|
|
2017
Q4 | $268M | Buy |
1,430,147
+43,076
| +3% | +$8.04M | 3.25% | 14 |
|
|
2017
Q3 | $234M | Sell |
1,387,071
-7,406
| -0.5% | -$1.12M | 2.85% | 17 |
|
|
2017
Q2 | $200M | Buy |
1,394,477
+478,777
| +52% | +$64.3M | 2.45% | 19 |
|
|
2017
Q1 | $115M | Buy |
915,700
+213,889
| +30% | +$24.8M | 1.53% | 25 |
|
|
2016
Q4 | $79.1M | Buy |
701,811
+97,847
| +16% | +$11.3M | 1.15% | 29 |
|
|
2016
Q3 | $77.7M | Buy |
603,964
+10,005
| +2% | +$1.2M | 1.14% | 26 |
|
|
2016
Q2 | $64.9M | Buy |
593,959
+135,436
| +30% | +$13.5M | 1.03% | 27 |
|
|
2016
Q1 | $43.5M | Buy |
+458,523
| New | +$38.7M | 0.72% | 30 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Brown Capital Management's ABMD Position: Q4 2022 in Review
Brown Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,260,466 shares — an estimated $310M sold.
Brown Capital Management first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $568M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Brown Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Brown Capital Management sold 1,260,466 Abiomed Inc shares in Q4 2022, an estimated $310M.
- Brown Capital Management first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
- Brown Capital Management's Abiomed Inc position peaked at $568M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Brown Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.